Biongevity Enhances Longevity Strategy with Harish Consul as Chief Venture Capital Advisor
CALGARY, Alberta, Sept. 04, 2024 (GLOBE NEWSWIRE) — Biongevity, a leader in precision health and longevity medicine, is pleased to announce the appointment of Mr. Harish Consul as Chief Venture Capital Advisor.
Canada’s First Precision Health and Longevity Summit Aims to Advance Global Healthspan Research
Discover your personalized roadmap to a longer, healthier life with Biongevity. Expert tips and insights for achieving optimal longevity.